![Rabia Ozden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rabia Ozden
No open positions remaining
Profile
Rabia Gurses Ozden worked as Executive Medical Director-Ophthalmology at Quark Pharmaceuticals, Inc. from 2011 to 2014.
The role of Vice President & Head-Clinical Ophthalmology was held at GSK Plc.
From 2015 to 2018, the position of Vice President-Clinical Research & Development was at Beacon Therapeutics (USA), Inc. Served as Assistant Professor at New York Medical College.
In 2019, the role of Chief Medical Officer was at Nightstar Therapeutics Ltd. From 2019 to 2021, Chief Development Officer was at Akouos, Inc. Chief Medical Officer roles were held at Ocular Therapeutix, Inc. from 2022 to 2024 and at Adverum Biotechnologies, Inc. from 2024 to 2025.
Education includes a doctorate degree from Hacettepe University.
Former positions of Rabia Ozden
| Companies | Position | End |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 09/12/2025 |
| OCULAR THERAPEUTIX, INC. | Chief Tech/Sci/R&D Officer | 20/05/2024 |
| AKOUOS | Corporate Officer/Principal | 01/01/2021 |
| NIGHTSTAR THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/12/2019 |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | 01/03/2018 |
Training of Rabia Ozden
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hacettepe University
 Hacettepe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
- Stock Market
- Insiders
- Rabia Ozden
